Croda Director Danuta Gray Buys Shares in Regulatory Disclosure

An announcement from Croda International ( (GB:CRDA) ) is now available.

Croda International has disclosed a share transaction involving non-executive director Danuta Gray, in line with regulatory requirements for reporting dealings by persons discharging managerial responsibilities. The notification confirms Gray’s status and role on the board and identifies Croda as the listed issuer subject to market transparency rules.

According to the disclosure, Gray purchased 750 ordinary shares in Croda International on 6 March 2026 on the London Stock Exchange at a price of £27.87596 per share. The aggregated value of the transaction was £20,906.97, providing investors with updated information on board-level share ownership and aligning with governance norms on timely director dealing notifications.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £34.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Spark’s Take on GB:CRDA Stock

According to Spark, TipRanks’ AI Analyst, GB:CRDA is a Neutral.

The score reflects solid financial stability (manageable leverage and positive cash generation) and supportive technical momentum, balanced against a demanding valuation (high P/E) and execution risk highlighted on the earnings call (exceptional charges and segment volatility despite improving guidance and transformation progress).

To see Spark’s full report on GB:CRDA stock, click here.

More about Croda International

Croda International Plc is a specialty chemicals company that develops and manufactures high-performance ingredients and technologies. Its products serve a range of markets including personal care, crop protection, pharmaceuticals, and industrial applications, positioning the group as a key supplier of value-added chemical solutions to global consumer and industrial brands.

Average Trading Volume: 579,617

Technical Sentiment Signal: Sell

Current Market Cap: £3.96B

See more data about CRDA stock on TipRanks’ Stock Analysis page.